After participating in this webinar, the learner will be able to:
- Describe the incidence and clinical impact of respiratory viruses (RVs) in lung transplant recipients (LTR).
- Explain the evidence linking RVI to chronic lung allograft dysfunction (CLAD).
- List currently available and promising investigational therapies for: RSV, Influenza, and PIV.
- Discuss prevention strategies.